A citation-based method for searching scientific literature

Ilkka Tikkanen, Kirsi Narko, Cordula Zeller, Alexandra Green, Afshin Salsali, Uli C Broedl, Hans J Woerle. Diabetes Care 2015
Times Cited: 253



Steven P Marso, Stephen C Bain, Agostino Consoli, Freddy G Eliaschewitz, Esteban Jódar, Lawrence A Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark L Warren, Vincent Woo, Oluf Hansen, Anders G Holst, Jonas Pettersson, Tina Vilsbøll. N Engl J Med 2016
Times Cited: 1842




List of shared articles



Times cited


Blood Pressure-Lowering Effect of Newer Antihyperglycemic Agents (SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors).
Charalampos I Liakos, Dimitrios P Papadopoulos, Elias A Sanidas, Maria I Markou, Erifili E Hatziagelaki, Charalampos A Grassos, Maria L Velliou, John D Barbetseas. Am J Cardiovasc Drugs 2021
0

Preventing Diabetes and Atherosclerosis in the Cardiometabolic Syndrome.
Muhammad Imtiaz Ahmad, Michael D Shapiro. Curr Atheroscler Rep 2021
0



Using adult stem cells to monitor endothelial dysfunction in diabetes mellitus.
Rohit Jain, Hassan Awal, Sabyasachi Sen. J Diabetes Complications 2020
3

The Evolving Understanding and Approach to Residual Cardiovascular Risk Management.
Devinder S Dhindsa, Pratik B Sandesara, Michael D Shapiro, Nathan D Wong. Front Cardiovasc Med 2020
7

The revolution of the anti-diabetic drugs in cardiology.
Paolo Verdecchia, Fabio Angeli, Claudio Cavallini, Adolfo Aita, Dario Turturiello, Gianpaolo Reboldi. Eur Heart J Suppl 2020
0

Blood pressure control in type 2 diabetes mellitus with arterial hypertension. The important ancillary role of SGLT2-inhibitors and GLP1-receptor agonists.
C Berra, R Manfrini, D Regazzoli, M G Radaelli, O Disoteo, C Sommese, P Fiorina, G Ambrosio, F Folli. Pharmacol Res 2020
3

Anti-inflammatory effects of sodium-glucose co-transporter 2 inhibitors on atherosclerosis.
Yingxiu Kang, Fenfen Zhan, Minzhi He, Zhenjie Liu, Xiaoxiao Song. Vascul Pharmacol 2020
1


Comparative safety of the sodium glucose co-transporter 2 (SGLT2) inhibitors: a systematic review and meta-analysis.
Jennifer R Donnan, Catherine A Grandy, Eugene Chibrikov, Carlo A Marra, Kris Aubrey-Bassler, Karissa Johnston, Michelle Swab, Jenna Hache, Daniel Curnew, Hai Nguyen,[...]. BMJ Open 2019
53

Novel pharmacological therapy in type 2 diabetes mellitus with established cardiovascular disease: Current evidence.
Leonardo Pozo, Fatimah Bello, Andres Suarez, Francisco E Ochoa-Martinez, Yamely Mendez, Chelsea H Chang, Salim Surani. World J Diabetes 2019
6